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Dutch health economic guidelines include a costing manual, which describes preferred
research methodology for costing studies and reference prices to ensure high quality stud-
ies and comparability between study outcomes. This paper describes the most important
revisions of the costing manual compared to the previous version.
Methods
An online survey was sent out to potential users of the costing manual to identify topics for
improvement. The costing manual was aligned with contemporary health economic guide-
lines. All methodology sections and parameter values needed for costing studies, particu-
larly reference prices, were updated. An expert panel of health economists was consulted
several times during the review process. The revised manual was reviewed by two members
of the expert panel and by reviewers of the Dutch Health Care Institute.
Results
The majority of survey respondents was satisfied with content and usability of the existing
costing manual. Respondents recommended updating reference prices and adding some
particular commonly needed reference prices. Costs categories were adjusted to the inter-
national standard: 1) costs within the health care sector; 2) patient and family costs; and 3)
costs in other sectors. Reference prices were updated to reflect 2014 values. The methodol-
ogy chapter was rewritten to match the requirements of the costing manual and preferences
of the users. Reference prices for nursing days of specific wards, for diagnostic procedures
and nurse practitioners were added.
Conclusions
The usability of the costing manual was increased and parameter values were updated. The
costing manual became integrated in the new health economic guidelines.
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Introduction
Economic evaluations in health care are increasingly used to inform decision makers on
value for money of health care interventions. Standardization of methodology for eco-
nomic evaluations is needed to ensure high-quality evaluations and obtain outcomes that
can be compared between health care interventions. For this purpose, pharmacoeconomic
guidelines have been developed in various countries [1]. These guidelines differ between
countries, for example with respect to which costs should be included, methodology of cal-
culating costs and discounting.
In 2015, The Dutch National Health Care Institute (ZIN) updated the pharmacoeconomic
guidelines to align formerly co-existing health economic guidelines in the Netherlands, con-
nect with guidelines in other countries and expand guidelines to non-pharmaceutical interven-
tions. The guidelines prescribe a societal perspective, meaning all relevant costs, should be
included in an economic evaluation. The guidelines and accompanying modules were pub-
lished in February 2016 [2,3]. The guidelines are accompanied by several ‘modules’, among
them a module for costing studies (hereafter the ‘costing manual’).
The purpose of the costing manual is to provide guidance to researchers and policy makers
to perform and evaluate economic evaluations of health care interventions. The first Dutch
costing manual was published in 2000. Since then, two updates were published in 2004 and
2010 [4]. The instrument has been widely used since the publication of the first costing man-
ual. Standard cost prices for various health care services, called reference prices, constitute an
important part of the costing manual. Regular updates of the costing manual are essential in
order to reflect changes in health care, price increases, and developments in HTA research.
This paper reports on the update of the Dutch costing manual which serves the purpose of har-
monizing the costing side of economic evaluations in health care. As the costing manual is
written in Dutch, this paper can provide international readers with a better understanding of
the content and methodologies used in the costing manual and provide them with the refer-
ence prices for healthcare services for the Netherlands.
Materials and methods
The revision of the costing manual was part of the new edition of the Dutch health economic
guidelines. The principles of the costing manual had to be aligned with these guidelines and
the reference prices were to be updated. The update of the costing manual consisted of three
separate steps. First, an inventory of user needs was made. Second, the content of the manual
was updated to resemble the health economic guidelines and adjust methodological para-
graphs. Furthermore, reference prices were updated through literature and database research
and stakeholder consultation. Third, members of the expert committee supervising the guide-
line revision for ZIN were asked to comment on intermediate and final results of the revision
of the costing manual. The revision of the costing manual was supervised by a team of ZIN
with experience in health economics and project management.
Inventory of user needs
An online survey was sent out to over 700 people (mainly from universities, industry, govern-
mental bodies, health care institutions and consultancy) from the target audience of the cost-
ing manual to investigate user satisfaction with the previous costing manual, and to identify
user needs and opportunities for improvement for the updated costing manual. The online
survey consisted of 13 questions, and encompassed three themes: clarity and user-friendliness
of the previous manual; methodological issues; and (need for additional) reference prices. The
online survey opened on January 15th 2015 and closed on February 2nd 2015. During this
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2015.), which is publicly available from the website
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period, one reminder was sent out to non-respondents. The survey questions are provided in
S1 Appendix.
Update of the costing manual
Changes to the content of the costing manual that were made to align with the new health eco-
nomic guidelines included incorporating a new typology of costs and consequently updating
the roadmap for costing studies. The roadmap describes the steps that are needed to conduct a
costing study [4]. It serves as a starting point for conducting costing studies and connects the
health economic guidelines to the costing manual.
Reference prices for health care consumption, which are average unit costs, constitute a fre-
quently used part of the costing manual. Reference prices were recalculated using recent infor-
mation on costs, volume and prices for various types of health care services. Reference prices
were updated using various techniques (summarized in Table 1), depending on data availabil-
ity. If possible, bottom-up microcosting was used to calculate reference prices, as this is the
gold standard for calculating cost prices [5]. When bottom-up microcosting data was not avail-
able, grosscosting methods were applied to calculate reference prices. Bottom-up microcosting
studies, identifying and valuating resource use per individual patient, were used to calculate
references prices for hospital care [Tan, S.S., et al. Reference unit prices for surgery, neurology
and paediatrics. Submitted for publication]. Reference prices for emergency care, ambulances,
blood products, daycare treatment in mental health care and rehabilitation were calculated
using top-down grosscosting, for which data on costs and volumes were derived from health
care providers. Data on expenditures and volumes derived from national health care database
were used to calculate reference prices using top-down grosscosting, for primary care physi-
cians, paramedical care, elderly care, home care, mental health care and health care for dis-
abled patients [6]. Finally, tariffs were used to value diagnostic procedures [7]. For contacts
with independent psychotherapists and psychiatrists, ambulatory consultation in a general
institution and inpatients days in mental health care tariffs were used [8]. Relevant stakehold-
ers were consulted to validate the updated reference prices. Updated informal care costs were
derived from the website of the Central Administration Office (CAK). Productivity costs
should be valued using the friction cost method based on the Dutch health economic guide-
lines. The friction period is equal to the average duration of a job vacancy plus an additional
Table 1. Sources used to calculate reference prices for various health care services.
Health care service Sources for reference prices
Hospital days Bottom-up costing studies
Outpatient visits Bottom-up costing studies
Emergency room visit Health care providers
Ambulance transport Health care providers
Primary care physician National health care database
Paramedical care National health care database
Elderly care National health care database
Home care National health care database
Mental health care National health care database, health care providers, tariffs
Rehabilitation therapy Health care providers
Health care for disabled patients National health care database
Informal care Central Administration Office
Friction period Statistics Netherlands
Wage rates Statistics Netherlands
https://doi.org/10.1371/journal.pone.0187477.t001
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four weeks. The average duration of job vacancies was calculated with the following formula:
365 / (the number of filled vacancies in one year / the number of vacancies at a moment in that
same year). The number of vacancies was derived from the website of Statistics Netherlands.
Wage levels were also derived from the Statistics Netherlands website.
Expert committee
An expert committee of 12 experienced health economists supervised the revision of the
Dutch health economic guidelines and were also asked to provide input to the costing manual
during the research period (January 2015 through June 2015). A draft report of the costing
manual was peer-reviewed by two members of the expert committee.
Results
Survey results
A total of 71 respondents completed the survey (non-response of about 90%). Respondents
were predominantly employed at universities and health care providers. Most respondents
agreed with the statements that the costing manual was user friendly (75%); clear (75%) and
well-written (76%). These outcomes were discussed with ZIN and the expert committee.
Although no pre-specified thresholds were used for these questions, the results were judged to
be sufficient. Respondents indicated that their main use of the costing manual was to obtain
reference prices; 86% of respondents stated to use the reference prices in costing studies or
economic evaluations. Reference prices not being available for health care services that were
investigated was the main reason for not using reference prices. Some respondents (n = 3)
stated that reference prices were outdated and two respondents questioned the reliability of
the reference prices. Alternative sources that were used by respondents to value health care ser-
vices were tariffs, DRG prices, empirical research, financial administrations and expert panels.
The relevance of the responses to the survey was judged by the authors, and discussed with
ZIN and the external expert committee. Respondents identified a number of potential
improvements for the costing manual. First, reference prices needed to be updated. Second,
reference prices for the previously ignored categories ‘nurse practitioner’ and ‘diagnostic pro-
cedures’ were requested. These were the only health care services for which reference prices
were requested by more than two respondents. Furthermore, respondents claimed that the
methodological description of calculating productivity losses and costs for medication use
could be improved.
Adaptations to the costing manual
In line with the revised health economic guidelines, in which the typology of costs was changed
to reflect the classification used in the Drummond textbook [9]; 1) costs within the health care
sector; 2) patient and family costs; and 3) costs in other sectors. Future medical costs, which
was a separate category in the taxonomy used in the previous costing manual, are included in
the category ‘cost within the health care sector’.
In the updated costing manual, the roadmap for costing studies was adjusted to reflect the
new classification of costs. The revised roadmap is provided in Fig 1 and comprises the follow-
ing seven steps: 1) select the perspective; 2) adopt an appropriate time horizon; 3) determine
cost categories; 4) determine cost units; 5) measure resource use; 6) value resource use; and
finally 7) include uncertainty around the estimates.
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Costs within the health care sector. The costing manual identifies the reference prices to
be the most appropriate to value costs within the health care sector. Table 2 provides the refer-
ence prices for the most important health care services.
An important refinement in the updated costing manual was the specification of unit prices
for hospital days and outpatient visits according to medical specialty, next to generic references
prices for hospital days and outpatient visits. Reference prices for hospital days ranged from
€395 at the neurology department, to €636 for a day at the hematology-oncology department.
Reference prices for outpatient visits ranged from €73 (surgery department) to €132 (hematol-
ogy-oncology department).
The methodology for calculating medication costs was simplified. Previously, a claw-back
had to be included in calculating medication costs, but due to changes in legislation the claw-
back has ceased to exist. The calculation of medication costs, currently consists of two compo-
nents: 1) the price of the medication itself (including VAT), which can be derived from www.
medicijnkosten.nl and 2) delivery costs of the pharmacy, which is €6.00 for regular deliveries.
In response to the survey outcomes, the updated version includes tariffs for the most com-
mon diagnostic procedures, such as common laboratory assessments, MRI and CT-scan. Gen-
erally, these tariffs come close to the actual costs. Tariffs for other diagnostic procedures can be
found on the website of the Dutch National health care authority (NZa) and are updated
regularly.
Furthermore, a reference price for nurse practitioner in mental health care was included
upon request of the survey respondents. Furthermore, the costing manual was supplemented
with reference prices for health care services for disabled patients.
Future medical costs related to the disease of interest can be assessed as current costs within
the health care sector. In contrast, future medical costs for unrelated diseases cannot be
assessed in the same way, as it cannot be predicted which unrelated diseases a patient will suf-
fer from in the future. Therefore, future medical costs for unrelated diseases have to be calcu-
lated on the basis of average health care usage per person, rather than calculating costs per
patient. The Practical Application to Include future Disease costs (PAID) can be used to do
this [10]. In PAID, double counting of related future medical costs is prevented, as the user
can identify which diseases are already included in the costing study. PAID corrects for the
observation that health care costs increase with age and are highest in the last year of life.
PAID is available online through www.imta.nl/paid.
Patient and family costs. The value of time on informal care is an important aspect of
patient and family costs and should be included in costing studies according to the Dutch
health economic guidelines. Data on the volume of informal care can be obtained by means of
Fig 1. Roadmap for costing studies.
https://doi.org/10.1371/journal.pone.0187477.g001
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Table 2. Reference prices for costs within the health care sector.
Health care service Reference price a
Inpatient hospital day (including materials, equipment, etc.)
- General hospital € 443
- University hospital € 642
- Weighted average € 476
Medical specialty
- Surgery € 405
- Neurology € 395
- Paediatrics € 627
- Haematology-oncology € 636
Intensive care unit day € 2015
Daycare treatment € 276
Outpatient visit (including materials, equipment, etc.)
- General hospital € 80
- University hospital € 163
- Weighted average € 91
Medical specialty
- Surgery € 73
- Neurology € 99
- Paediatrics € 101
- Haematology-oncology € 132
Emergency room visit € 259
Primary care physician/General practitioner € 33
Paramedical care (per visit)
- Physical therapy € 33
- Exercise therapy € 34
- Speech therapy € 30
- Occupational therapy € 33
Elderly care
- Inpatient elderly care incl. daycare, per day € 168
- Daycare € 67
Home care (per hour)
- Household activities € 20
- Personal care at home € 50
- Support at home € 58
- Nursing at home € 73
- Home treatment € 120
Mental health care (per visit)
- Primary care physician € 66
- Nurse practitioner € 17
- Social worker € 65
- Primary care psychologist € 64
- Independent psychotherapist € 94
- Independent psychiatrist € 94
- Ambulatory consultation general institution € 98
- Inpatient day € 302
- Daycare treatment € 169
Rehabilitation therapy
(Continued )
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diaries or questionnaires. An updated reference price for informal care was calculated using
the opportunity cost method [11] and was determined to be €14 per hour. Another compo-
nent of patient and family costs are travel costs, for which parameter values were also updated.
The average distance to a hospital in the Netherlands was 7.0 kilometres; the average distance
to a GP was 1.1 kilometres. Costs per kilometre were €0.19 by public transport or by car
(excluding parking costs of €3.00 per visit).
Costs in other sectors. The third type of costs in the Drummond taxonomy are costs
in other sectors. An important component of costs in other sectors is costs due to lost produc-
tivity. The Dutch health economic guidelines prescribe the inclusion of productivity losses in
economic evaluations. Productivity costs should be calculated using the friction cost method,
which assumes that productivity costs are only incurred during the period between the mo-
ment an employee falls ill and the moment the employee is replaced, the so-called friction
period [12]. All parameters needed to calculate productivity losses with the friction cost
method were updated; the friction period was estimated to be 85 days and average wage rates
were updated, equalling €34.75 per hour. When an intervention is solely focussed on men or
women, gender-specific wage rates can be used (€37.90 per hour for men and €31.60 per hour
for women). In response to survey respondents’ requests, the description of methodology to
calculate productivity losses was improved. Three examples were included to provide hands-
on information on how to calculate productivity costs.
Dissemination of costing manual and reference prices
Along with the updated costing manual, a Microsoft Excel instrument was developed that con-
tained all updated reference prices and parameters in the costing manual. The instrument will
be hosted by ZIN and enables users to quickly find reference prices. Furthermore, users can
select a reference year, resulting in inflation-corrected reference prices.
Discussion
The costing manual is an essential part of the revised Dutch health economic guidelines, which
were published in February 2016. The costing manual describes the methodology of costing
studies and reference prices, which are used to increase the quality and comparability of cost-
ing studies. As such, the costing manual is a widely used instrument for costing studies and
economic evaluations in health care in the Netherlands. This paper describes the updates in
the revised version of the Dutch costing manual. Important revisions were simplification of
methodology and updates of reference prices, including those for a number of hospital
Table 2. (Continued)
Health care service Reference price a
- Rehabilitation therapy per hour € 153
- Daycare treatment (children) € 521
- Daycare treatment (adults) € 460
Health care for disabled patients
- Inpatient care for mentally disabled patients incl. daycare, per day € 209
- Inpatient care for physically disabled patients incl. daycare, per day € 205
- Inpatient care for aurally disabled patients incl. daycare, per day € 310
- Inpatient care for visually disabled patients incl. daycare, per day € 217
a Sources and calculations are provided in the costing manual [13]
https://doi.org/10.1371/journal.pone.0187477.t002
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specialties and diagnostic procedures. The updated costing manual is freely available from the
website from ZIN (www.zorginstituutnederland.nl) together with an online Microsoft Excel
instrument containing the reference prices to ensure accessibility (available through www.
imta.nl/costingtool).
Standardization of methodology for health economic studies enables comparison of studies’
outcomes within countries. Internationally, differences in health economic guidelines remain
[1]. One particular factor that differs between national guidelines concerns the perspective of
economic evaluations, i.e. whether studies should adopt a health care perspective or a wider,
societal perspective [14]. Even in countries that adopt a societal perspective and include pro-
ductivity costs, the methodology to calculate productivity costs can differ–the Netherlands is
one of the few countries that applies the friction cost method [4]. The detailed description of
this methodology in the costing manual, including examples, is therefore essential for a good
understanding of this approach. The iMTA productivity cost questionnaire (iPCQ) can be
used to quantify productivity losses, and enables calculation of productivity costs according to
the friction cost method [15]. The accompanying manual provides a step by step explanation
on measuring and valuing productivity losses [16].
Furthermore, adopting a societal perspective also entails including costs of informal care.
Research has shown that including informal care costs can influence the outcomes of a cost-
effectiveness study considerably [17]. The use of a single reference price as provided in the
costing manual is therefore essential, as the use of informal care is increasing [18].
Health economic guidelines prescribe the use of country-specific unit prices, to reflect abso-
lute and relative differences in unit prices [19]. However, a recent study found that a standard
cost list, such as the reference prices provided in the costing manual, is only available in four
out of 30 pharmacoeconomic guidelines [20]. Use of a costing manual and reference prices
ensures that differences in costs result from differences in health care utilization and not from
the methodology applied to calculate costs. The absence of standard prices leads to differences
in valuation of the same health care service within a single country, and can influence study
outcomes and potentially even reimbursement decisions. Next to reference prices published in
the costing manual, the manual provides guidance on the methodology of calculating unit
prices when reference prices are not available. As such, using standard methodology increases
the comparability and transparency of unit prices used in costing studies. In this way, the
Dutch costing manual can be a useful tool for developing costing manuals in other countries.
Limitations
This paper provides reference prices for the most important health care services. The use of
reference prices increases the comparability between studies. However, a balance between
standardization and the specific situation of an economic evaluation has to be found. Differ-
ences in costs between providers or patients are not accounted for in reference prices. For
those economic evaluations in which one particular type of health care has a large impact on
the results, researchers should therefore ensure that reference prices reflect the costs of the sit-
uation specific to their study.
For diagnostic procedures, reference prices were not available. Tariffs were considered to be
an accurate estimate of actual costs of diagnostic procedures. Mental health care covers different
echelons, and ranges from contacts with mental health nurse practitioners to inpatient days.
Some, but not all, estimates of the various reference prices for mental care were based on tariffs.
For instance, reference prices for contacts with mental health nurse practitioners, primary care
psychologists and primary care physician were based on the total costs divided by the total num-
ber of contacts/days. In case we necessarily had to base the estimates on tariffs, we used charges
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for contacts or hospital days not reimbursed by public health care. These are the charges clients
have to pay if they are not covered under the Dutch Healthcare Insurance Act. These tariffs are
assumed to reflect the actual costs in the best possible way, as these are calculated using the
actual input of personnel and resources. Unfortunately, the researchers did not have access to
the calculations and hence were not able to recalculate these estimates. For now, face validity
seems to verify these reference prices, but further research is recommended.
The requested reference price for a nurse practitioner could only be provided for nurse
practitioners in mental health care, as the available data did not allow to estimate a reference
price for general nurse practitioners in a GP setting. Bottom-up research is needed to deter-
mine the reference price for general nurse practitioners in this setting.
Bottom-up costing studies are considered the gold standard for calculating cost prices [5].
However, this method is time consuming and costly. Therefore, due to data availability, refer-
ence prices in the costing manual could not be based solely on bottom-up costing studies.
When additional bottom-up costing studies will be performed in the future, the resulting
prices might replace existing reference prices in future updates of the costing manual.
The response rate of the online survey was approximately 10%. However, as the purpose of
the survey was identification rather than quantification of user needs, the low response rate
was not considered problematic.
Future updates of the costing manual
The values in the costing manual should be regularly updated, to ensure that methodology
reflects current best practice and reference prices reflect current price levels. Future updates
also entail including additional reference prices for other types of health care and more
detailed reference prices, for instance for other hospital specialties. The expert committee pro-
posed that one way to increase the availability of reference prices is to set up an open reposi-
tory, in which researchers can share unit prices derived in their own studies. However, a
number of questions need to be answered before such a repository could be established, such
as, who would be responsible for hosting the repository, who should finance the repository,
what requirements should be used to assess the quality of reference prices and who should be
responsible for checking the quality of the reference prices. In this respect, the Excel tool is par-
ticularly useful, as this instrument can be updated more quickly than a hard-copy of the cost-
ing manual. An upcoming English translation of the online instrument also enables foreign
users to easily access Dutch reference prices, and consequently further increase transparency
and comparability of Dutch costing studies in health care.
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